z-logo
open-access-imgOpen Access
The Debrisoquine Metabolic Phenotype and DNA-Based Assays: Implications of Misclassification for the Association of Lung Cancer and the Debrisoquine Metabolic Phenotype
Author(s) -
N. E. Caporaso,
P. G. Shields,
M. T. Landi,
G. L. Shaw,
M. A. Tucker,
R. Hoover,
H. Sugimura,
A. Weston,
C. C. Harris
Publication year - 1992
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.2307/3431254
Subject(s) - debrisoquine , biology , genotype , restriction fragment length polymorphism , genetics , cyp2d6 , allele , lung cancer , phenotype , pharmacogenetics , gene , microbiology and biotechnology , medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom